About the Authors
- Xinxue Liu
-
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
- Angela Wong
-
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
- Sudarshan R. Kadri
-
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
- Andrej Corovic
-
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
- Maria O’Donovan
-
Affiliation Department of Histopathology, Addenbrooke’s Hospital, Cambridge, United Kingdom
- Pierre Lao-Sirieix
-
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
- Laurence B. Lovat
-
Affiliation University College London Hospital (UCLH), London, United Kingdom
- Rodney W. Burnham
-
Affiliation Queen’s Hospital, Romford, Essex, United Kingdom
- Rebecca C. Fitzgerald
-
* E-mail: rcf@hutchison-mrc.cam.ac.uk
Affiliation MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom
Competing Interests
Rebecca Fitzgerald has developed the Cytosponge technology which has been licensed to Covidien since this study was completed. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: XL AW RCF. Performed the experiments: AW. Analyzed the data: XL. Wrote the paper: XL AC RCF. Inputted data: AW PLS SRK AC. Provided expert histopathological diagnosis: MO. Managed patient recruitment: AW SRK RWB. Oversaw patient recruitment: LL.